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Abstract
Background: Cognitive decline poses a great concern to elderly people and their families. In addition to
pharmacological therapies, several varieties of nonpharmacological intervention have been developed. Most
training trials proved that a well-organized task is clinically effective in cognition improvement.
Main body: We will first review clinical trials of cognitive training for healthy elders, MCI and AD patients,
respectively. Besides, potential neuroprotective and compensatory mechanisms in animal models of AD are
discussed. Despite controversy, cognitive training has promising effect on cognitive ability. In animal model of AD,
environmental enrichment showed beneficial effect for cognitive ability, as well as neuronal plasticity. Neurotrophin,
neurotransmitter and neuromodulator signaling pathway were also involved in the process. Well-designed
cognitive activity could benefit cognitive function, and thus life quality of patients and their families.
Conclusion: The positive effects of cognitive activity is closely related with neural plasticity, neurotrophin,
neurotransmitter and neuromodulator signaling pathway changes.
Background
Cognitive decline and its burden
Cognitive decline is age-specific or related with demen-
tia. Alzheimer disease (AD) was the most common types
of dementia. In 2006, the global prevalence of AD was
26.6 million [1]. It is estimated that the one in 85 per-
sons worldwide will suffer from the disease by 2050. In
the United States, AD causes estimated health-care costs
of $172 billion per year [2]. It was reported that average
total costs for AD patients were more than five-fold
higher compared with matched controls [3]. If interven-
tions could delay disease onset and slow its progression
by a modest 1 year, there would be much fewer cases of
the disease in 2050 with reduction by nearly 9.2 million,
and thus fewer expenditure on care and treatment [1].
As a continuous course, Alzheimer’s disease (AD) grad-
ually develops from preclinical state, mild cognitive im-
pairment (MCI) to dementia. MCI can thus be regarded
as a transitional state between normal aging and AD.
Aging and aging-related diseases pose a major threat
to individuals’ life quality, and cause high economic bur-
den on families and the whole society. Prevalence of
MCI in population-based epidemiological studies ranges
from 3 to 20% in adults older than 60 or 65 years old
[4–7]. Some people with MCI seem to remain stable or
return to normal over time [5]. However, approximately
50% of patients with MCI (roughly 12% per year) will
progress to AD over 4–5 years.
Unfortunately, there is no cure or robust pharmaco-
logic treatment for AD. So far, the primary focus is slow-
ing down the decline of neurological and associated
behavioral functions, by providing medications, training
and caregiver support.
Pharmacological and non-pharmacological therapies
Due to the increasing prevalence of MCI and AD,
pharmacological and non-pharmacological treatments
have been greatly concerned about their effects. Donepe-
zil, rivastigmine, galantamine, and memantine are the
drugs presently approved by the Food and Drug Admin-
istration (FDA) for treatment of AD. Meta-analysis of
cholinesterase inhibitors (ChEIs) showed their effects by
a small improvement in activities of daily living [8].
Antiglutamatergic treatment (memantine) reduced
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clinical deterioration in moderate-to-severe Alzheimer’s
disease [9]. In addition, it is still doubted that whether
these drugs significantly improve long-term outcomes,
such as the need for nursing home admission [10, 11].
Both ChEIs and antiglutamatergic treatment are not
indicated for MCI patients. A review and meta-analysis
concluded that treatment with cholinesterase inhibitors
merely affected MCI progression to dementia or im-
proved cognitive test scores [12]. In one study of data
from Alzheimer’s Disease Neuroimaging Initiative, MCI
patients who received ChEIs with or without memantine
were more impaired, showed greater decline in scores,
and progressed to dementia sooner than patients who
did not receive ChEIs [13].
As well as medications, non-pharmacological interven-
tions also aim to delay the loss of cognitive abilities, to help
people stay independent in everyday life as long as possible,
and to increase their well-being and quality of life. Because
of its readiness and few side effects, not only AD or MCI
patients, healthy elder adults can also participate at home
or in the community. There are various approaches,
including mental exercise, diet control and physical exer-
cises [14, 15]. However, their effect remains controversial in
different clinical trials. Other interventions include art
therapy, aromatherapy, music therapy, animal-assisted ther-
apy and caregiver education programs.
From bedside to bench
There have been a large number of clinical trials and re-
views about the effect of cognitive therapy for aging pop-
ulations [16–18]. Computerized cognitive training
showed its modest effect on cognitive performance in
healthy older adults [19], and the effect of cognitive
training was equivocal for AD patients [20]. Effective
forms of training for AD patients included errorless
learning, spaced retrieval, vanishing cues techniques,
and the dyadic approach [21]. However, few of these re-
views covered clinical outcomes and their underlying
mechanisms together.
In this paper, we first review clinical trials of cognitive
training for people with different extent of cognitive
ability. The characteristics and special outcomes of the
clinical trials of cognitive intervention were discussed, as
well as shortcomes of clinical studies. Then, much atten-
tion was devoted to neural mechanisms of these train-
ing, exploring valuable information from animal studies.
Cognitive activity for human beings
Method for literature review of clinical trials
We take two steps in the literature review. In step one,
we searched relevant meta-analysis for a quick look at
the effect of cognitive intervention. In step two, we se-
lected consolidated clinical trials for detailed analysis
and discussion.
Step One: Several systemic reviews and meta-analysis
have summarized cognitive training trials. Firstly, we
selected the work which fully complies with the Preferred
Reporting Items for Systematic Reviews and Meta-Analy-
sis (PRISMA) or Delphi list. We searched PubMed- and
PsycINFO-based literature for relevant meta-analysis
using the following Boolean strategy: “cognitive stimula-
tion” OR “cognitive rehabilitation” OR “cognitive activity”
OR “cognitive intervention” OR “training” OR “memory
training” OR “mnemonic training”. After screened by title
and abstract, meta analysis studies were included if they en-
rolled latest clinical trials that evaluated the effect of the
cognitive intervention by assessing cognitive changes before
and after intervention (Table 1).
Step Two: In order to further take a close look at the
entire literature and details, we manually searched
consolidated evidence from the references of selected
articles and earlier review [16]. We also searched for
published intervention studies in latest 5 years, limiting
to English language, human and peer reviewed articles.
The search strategy in PubMed (clinical trials as article
type) was shown as an example: (“Dementia”[Mesh] OR
“Alzheimer Disease”[Mesh] OR “mild cognitive impair-
ment”[Mesh] OR aging OR elder) AND (cognitive train-
ing OR mental training OR train* ) AND (Intervention
Studies OR intervention study OR intervention OR
interventions OR interventional OR experimental)
We selected studies by three steps based on eligibility
criteria of PRISMA checklist : the title and abstract
screening, full-text assessment for rationale and eligibil-
ity of methodology, and final evaluation of results. Two
reviewers (L, BY and W, Y) independently checked the
following factors before inclusion, and discrepancy was
discussed to arrive at agreement: subjects, study design,
blinding, withdrawals and dropouts, intervention
method and duration. Studies were excluded if they only
enrolled participants with other dementias or no clearly
intervention description. Eligible studies were classified
by cognition level of subjects, in order to find out train-
ing effect on people of different cognitive ability.
Impact of cognitive activity for healthy older adults
Studies description
Normal aging causes natural decline in multiple cogni-
tive domains, and thus poses threat to maintaining inde-
pendence and quality of life. Researchers tended to
develop methods to slow down the speed of cognitive
decline, based on the theory that brain retains some
plasticity. Since 1980s, a number of studies had tried
cognitive interventions for healthy older adults, in order
to improve cognitive performance and quality of life
[22–25]. These interventions included both laboratory-
based and community-based cognitive trainings for
healthy older adults.
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Models of intervention
As memory loss is the major and early complaint from
older adults, memory training was dominantly adopted
in a number of studies as early as 1980s [26–29]. Work-
ing memory training was conducted in 39 80-year-old
healthy adults, including visual free-recall tasks [30].
Both training effect (working memory ability) and trans-
fer effect were found improved immediately after train-
ing. Nevertheless, after 1-year follow up, both effects
were not significant. The pooled data also found its con-
troversial or negligible effect [31, 32]. Spatial working
memory task with 2 levels of processing demands helped
older adults (70–80 years old) to gain substantial
performance on the practiced task. The effects trans-
ferred to a more demanding spatial n-back task and to
numerical n-back tasks. Both benefits lasted for
3 months, while no evidence was found for far transfer
to complex span tasks [33]. Perceptual and verbal work-
ing memory training also showed their promising trans-
fer and maintenance effects [34, 35].
More studies paid attention to comprehensive training
covering more cognitive domains. Jobe et al. conducted
a famous large-scale, randomized, controlled, single-
masked trial (ACTIVE study) in 2001, which was de-
signed to determine whether cognitive interventions
could affect cognition-based daily functioning and basic
trained abilities served as mediators [36]. The ACTIVE
study has three models of intervention: speed of process-
ing, memory and reasoning. Each intervention improved
the targeted cognitive ability compared with baseline,
durable to 2 years. If individuals received booster train-
ing 11 months after initial training (2 to 3 weeks), train-
ing gains were enhanced and maintained at 2-year
follow-up. However, training effect did not transfer to
other untrained cognitive skills. In addition, the authors
also estimated training effects (cognitive change), com-
pared with expected decline in elderly persons without
dementia. The effects from speed of processing, memory
and reasoning training were respectively of a magnitude
equivalent to the amount of 2-, 7- and 14-year cognitive
decline expected in elderly persons without dementia.
The study did not find the changes of activities of daily
living. The authors attributed it to minimal functional
decline across all groups [37]. The study continued and
Table 1 Meta-analysis studies for cognitive training in healthy elders, MCI and AD patients
Reference Participants Training Trials Positive outcomes Negative outcomes
Lampit, et al.,
2014 [19]
Healthy elders Computerized cognitive training 51 Overall effect; nonverbal, verbal and working
memory; processing speed
EF and attention
Toril, P. et al.,
2014 [200]
Healthy elders Vedio game training 20 Reaction time, attention, memory, and global
cognition
EF
Kelly, ME et al.,
2014 [192]
Healthy elders Memory-based intervention/diverse
stimulations.







Papp, K. et al.,
2009 [201]
Healthy elders Multi-domain training 10 All outcome measuresc -
Li, H. et al.,
2011 [202]
MCI Multi-domain training 17 Overall cognition, self-ratings, EM, WM, EF SM, PS, attention, VS
Martin, M. et al.,
2011 [203]
Healthy elders Multi-domain training 11 Immediate recalla -
6 Delayed recalla -
2 - VS




AD + VD Multi-domain training 11 - Any reported
outcomes
Aquirre, E . et al.,
2013 [205]
Dementia b Cognitive and social function 7 ADAS-Cog -
Sitzer, DI. et al.,
2006 [206]
AD At least one domain cognitive
function
17 Overall cognitive ability -
Woods, B. et al.,
2012 [207]
Dementia b Cognitive stimulation 7 ADAS-Cog -
EF executive function, WM working memory, MCI mild cognitive impairment, EM episodic memory, PS processing speed, VS visual-spatial ability, VD
vascular dementia
aImprovements observed did not exceed the improvement in the active control condition
bAlzheimer’s disease, vascular dementia mixed Alzheimer’s and vascular dementia, other types of dementia. ADAS-Cog was applied only in AD patients
cSignificant but negligible
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showed improvement of targeted cognitive abilities for
10 years by reasoning and speed, but not memory [38].
Speed of processing training was also believed to be use-
ful in helping driving mobility [39], though its effect was
doubted in a new large-sample trials when compared
with crossword puzzle game [40].
Donostia Longitudinal Study aimed at all cognitive func-
tions. The authors compared structured training program
with unstructured one and control in a 2-year time span.
Each participant in experimental groups received 180
ninety-minute sessions (every session per week). Struc-
tured intervention covered the cognitive functions of
attention and orientation, memory, language, visuocon-
structive ability, executive functions, visuomanual coord-
ination and praxia. Only the group that received
structured intervention got higher scores in nearly all cog-
nitive tests [41]. Similar computerized cognitive training
also boosted memory/attention improvement in the ex-
perimental group (word list total score, word list delayed
recall, digits backwards, letter-number sequencing) [42],
as well as better mood and sleep [43].
In addition to these training programs for particular
one or more cognitive domains, social activities or
everyday activity were also evaluated as a kind of inter-
vention [44]. Some manipulations included social com-
munication, making sense of figures, drawing activities,
and even word-logic puzzles in the community or nurs-
ing home [45]. Some training also covered problem-
realization and strategy-seeking, helping develop
personal strategies for each participant [46]. A large-
scale RCT (FINGER study) combined diet, exercise,
cognitive training and vascular risk monitoring for im-
provement or maintenance of cognitive functioning. The
results suggested that 2-year multi-domain intervention
could improve or maintain cognitive functioning in at-
risk elderly people [47].
Cognitive activity for mild cognitive impairment patients
Studies description
Studies varied in the interventions, study design,
duration of sessions and sample size. All programs
mainly aimed at explicit memory because individuals
with MCI suffered from memory deficiency. Similarly to
intervention for healthy old adults, attention, speed of
processing, language, visual-spatial abilities and execu-
tive functions were also adopted [48–51], while others
only combined attention and memory training [52, 53].
Computerized cognitive training was also introduced
here for some multifaceted interventions [48, 49, 53]. It
could facilitate the individual’s approach but did not
show increased improvement when compared to non-
computerized training, independent of participants’ com-
puter familiarity [54].
Interventions for one or more multiple cognitive domains
In the early 2000s, Rapp et al. tried multi-component
memory interventions. Patients received education about
symptoms of memory loss, memory skills training, and
memory-related beliefs. Treated group did better in
memory assessment at the end of treatment and at a
6-month follow-up [55].
In a prospective study, Rozzini et al. used training cov-
ered different cognitive functions for patients with MCI.
After 1-year follow-up, subjects treated with training and
cholinesterase inhibitors (ChEIs) medication showed sig-
nificant improvements in memory, abstract reasoning and
in behavioral disturbances. The combined treatment group
showed its advantage over ChEIs group [48]. Wenisch et al.
administered a cognitive stimulation program (both
memory manipulation and information about memory
functioning) for cognitive performance. It revealed a larger
intervention benefits in MCI than in normal elders’ perfor-
mances on the associative learning task [56].
In addition to memory, behavior rehabilitation was
once believed to be a potential cognitive helper. Never-
theless, it is a bit controversial of its effect in MCI
patients. Greenaway et al. tested a calendar/notebook
system, including three sections: appointments; daily “to
do” items and important events that happened that day.
Patients compliant with the system had a medium effect
size for improvement in functional ability. Subjects fur-
ther reported improved independence, self-confidence,
and mood [52]. By contrast, Talassi et al. provided a
combined cognitive program training and found an
improvement in cognitive and affective status of patients
with MCI, while no effects were observed in a rehabilita-
tion program not providing a punctual stimulation of
cognitive functions [49].
Memory strategy intervention
Another critical factor in cognitive training is the use of
strategy. Strategy acts as a compensator in functioning.
Belleville et al. focused on episodic memory strategies
by comparing pre-and post-intervention difference.
Progress was remarkable in delayed list recall and face-
name association tasks of strategy-intervention group,
while no improvement was observed in MCI individuals
without receiving the intervention [57]. Hampstead et al.
taught MCI patients the use of explicit memory strat-
egies in classic face-name association tasks. Significant
improvement was also found on both trained and
untrained stimuli, raising the possibility of generalization
of training strategies [58].
After being taught with memory strategies based on
meta-memory, old adults had training-related gains in a
recall task, as well as transfer benefits in short-term
memory, long-term memory, working memory and mo-
tivation [59]. Strategy-based tasks can be viewed as the
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acquisition of knowledge that capitalizes on flexibility to
improve performance [60]. Performance may increase
because the person has acquired knowledge relevant for
the particular task.
Londos et al. also aimed at developing compensatory
memory strategies that can improve their cognition, as
well as occupational performance and quality of life. The
study compared cognitive function, occupational per-
formance, and self-perceived quality of life before and
after intervention. Significant improvements were seen
in cognitive processing speed, occupational performance
after participation in the program 2 days per week for
8 weeks [61]. Troyer et al. evaluated the effectiveness of a
multidisciplinary intervention, providing evidenced-based
memory training and lifestyle education to optimize mem-
ory behavior. After treatment, patients had increased
memory-strategy knowledge that could change their
everyday memory behavior by putting this knowledge into
practice. Interestingly, no improvement of objective mem-
ory performance was observed [62].
Cognitive activity for AD patients
Studies descriptions
Since publication in the early 1980s by Zarit et al., much
work has been done for cognitive stimulation in popula-
tions suffering from dementia, especially AD. The early
detection and diagnosis of AD raised the importance of
effective psychological intervention in the early stage.
Types of stimulation programs covered all cognitive do-
mains. Similarly to interventions for normal older adults
and MCI patients, memory is the main target, as well as
memory strategies and external memory aids. However,
due to poor cooperation of AD patients, more delicate
techniques were adopted.
Memory interventions
In contrary to its general application in MCI patients,
memory intervention was questioned when it is applied
in AD patients. Quayhagen et al. compared cognitive
stimulation with other non-pharmacological interven-
tions (dyadic counseling, dual supportive seminar, and
early-stage day care). Cognitive stimulation group dem-
onstrated more improvement over time only in cognitive
outcomes [63].
Zarit et al. tried visual imagery for overcoming mem-
ory loss in senile dementia patients in community.
Though recall performance (imagery techniques were
taught) was improved for subjects in the intervention
group, the author claimed its little practical value for
caregivers [64]. Imaginary memory task (classic face-
name association training) was also tried for AD. In a
study of 7 AD patients, only one AD patient increased
the time during which face-name associations could be
held in memory. No training gains were observed for the
remaining six patients, thus questioning the generalizability
of this method in enhancing memory in dementia [65].
In a combined intervention consisting of face-name
associations, spaced retrieval, and cognitive stimulation,
37 patients with probable AD were enrolled for 5 weeks.
AD patients who received stimulation showed significant
improvement in trained tasks, while no benefit was ob-
served in the additional neuropsychological measures of
dementia severity, verbal memory, visual memory, word
generation, motor speed, or caregiver-assessed patient
quality of life [66].
Errorless learning and spaced retrieval
Errorless learning was an instructional design introduced
in the 1930s in order to create the most effective learn-
ing environment. Errors are once regarded as a function
of learning and vice-versa. However, in the errorful
learning, people with amnesia much more easily remem-
ber their own mistakes than they remember the correc-
tion (which is usually the answer they hear from
someone else). Errorless learning is an alternative way to
get someone to learn something without the opportunity
to make a mistake.
In addition to traditional memory or cognitive inter-
vention, errorless learning provides a useful additional
strategy. Patients should be tailored to interventions,
based on errorless learning principles and specific cogni-
tive problems. In one study, five of the six participants
showed significant improvement on the target measures,
and maintained this improvement up to 6 months later
[67].
Spaced retrieval requires users to rehearse learned in-
formation at a certain time. Each new rehearsal is done
with a longer or equal interval between itself and the
previous rehearsal. At the end of every trial period there
is a test phase [68]. Landauer and Bjork first described
five types of this learning technique in 1978, and the
effectiveness of the rehearsal types was measured by
seeing how accurately participants responded during a
test phase [69].
Schacter et al. applied the technique to people suffer-
ing from amnesia and other memory disorders. Partici-
pants were asked to remember some fact with increasing
intervals. If the subject is able to recall the information
correctly the time is doubled to further help them keep
the information fresh in their mind to recall in the
future. The findings showed that using spaced retrieval
help name face association of young students, as well as
individuals with memory disorders [70]. The technique
helped demented patients able to place the information
in their long-term memory, remembering particular ob-
jects names, daily tasks, name face association, informa-
tion about themselves, and many other facts and
behaviors [71]. Spaced retrieval also showed advantage
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in long-term outcome, which lasted weeks even months
later [71].
Spaced-retrieval method was combined with trad-
itional memory stimulation tasks. The term “prospective
memory” refers to the timely execution of a previously
formed intention. In 1991, it was used for training four
AD patients to remember and to implement an intention
for future action. All participants were able to shift to
new task requirement, and all learned three successive
coupon colors successfully [72]. A pilot study designed
similar prospective memory tasks, consisting of errorless
learning and spaced retrieval techniques. Results showed
that AD patients who received prospective memory
training performed another similar task successfully
across 7 weeks post-treatment [73].
Training effect on brain activity from clinical perspectives
Neuronal mechanisms underlying the effects of these in-
terventions were investigated by functional magnetic
resonance imaging (fMRI) and electroencephalography
(EEG). When training and tasks in the fMRI were the
same (name-face association) for 6 MCI patients, in-
creased activation was observed in the medial frontal
cortex, parietal and occipital lobes neighboring the
temporal-parietal junction, left frontal operculum and
some areas of the left temporal cortex. It also revealed
increased generally connectivity after training, particu-
larly involving the medial temporal gyrus and foci in the
occipital and precuneus cortices [74]. In a control study,
2-month verbal memory training improved left hippo-
campal activation [75], suggesting neuroplasticity related
with cognitive training in the hippocampus in MCI.
Cortex also involves in memory trainings, especially
when training and tests in fMRI involved different cog-
nitive processes. A combination of specialized areas (ac-
tivated areas during pre-training and new areas during
post-training) was activated in the frontal, temporal and
occipital areas. Right inferior parietal lobe was the only
activated area that correlated with performance [76].
When tasks were visuospatial mnemonic, occipito-
parietal and frontal brain regions had increased activity
in younger adults. In older adults, only those that
showed increased occipito-parietal activity benefited
from the mnemonic. In the next section, more evidence
suggested connectivity changes between different brain
regions in combined cognitive training.
In gist reasoning training, higher fractional anisotro-
phy was found after 1-year training using diffusion
tensor imaging (DTI) MRI [77]. DTI also revealed
microstructural changes of limbic system structures
(hippocampus and para-hippocampus) among young
adults after a 2-h spatial learning and memory task [78].
A review of 20 research articles indicated that the
most robust evidence among elderly adults was a
change in anterior hippocampal volume with cognitive
activities [79].
Connectivity between different brain areas may change
during and after some specific cognitive manipulations.
A 6-week training program for healthy older adults on
Brain Fitness (an adaptive auditory perception computer
game) showed improvement in the activities of daily liv-
ing (a transfer effect from sensory processing to everyday
problem solving). It also selectively increased the integ-
rity of occipito-temporal white matter in the ventral at-
tention network, and decreased connectivity between
superior parietal cortex and inferior temporal lobe [80].
This indicates that top-down sensory processing training
is associated with improvements in untrained everyday
problem solving, depending on changes in the ventral at-
tention network, rather than on the connectivity be-
tween the parietal cortex and the temporal lobe.
Neurons interaction could also be evaluated by EEG
performance, taking its advantage of high temporal
resolution. EEG coherence indicates synchronization
between different cortical areas [81, 82]. After training
of attention maintenance for 1 month, healthy elder par-
ticipants demonstrated better performance, with remark-
able increase in theta power and long-rang theta
coherence between frontal and posterior brain regions
[83]. EEG was used to evaluate participants before and
after training in one study and revealed neural evidence
of functional plasticity in older adult brains. The
training-induced modifications in early visual processing
during stimulus encoding predicted working memory ac-
curacy improvements [34]. However, cognitive process
could not be evaluated by EEG, since it is usually done
when patients are under resting state.
Event-related potentials (ERP) [84] were used to find
task-related neural discharges. An ERP study for visual
search task showed that 10-week training improved at-
tention resource allocation and capacity, by increasing
N2pc and P3b amplitudes [85].
Despite the methodological limitations in both fMRI
and EEG studies, such as small sample sizes and lack of
control groups, these evidence suggested that elder indi-
viduals exhibit high plasticity, which can be used as a
clue to understand the effects of cognitive interventions.
Why we turn to bench for more help?
Trials above provided exciting results for clinical prac-
tice. However, there are several problems confusing and
unsolved. We raise the following reasons that make us
turn to laboratory for more help.
At first, the selection and publication bias of clinical
trials could not be ignored. AD has its owe pathological
characteristics, and preclinical AD happened without
any symptoms. Most of the clinical trials only lasted for
a relatively short period and only evaluated participants
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by neuropsychological assessment. It is not sure that
they enrolled participants of the correct diagnosis.
Besides, some “normal aging” or MCI participants at
baseline might progress to AD during follow-up, but few
trial corrected the bias when enrollment. In this way,
classic animal models of AD may help to find more con-
solidated evidence for cognitive intervention.
We once reviewed and concluded several principles
for an effective training program [86], based on current
clinical trials. However, before we design a training pro-
gram, it is more important to find subjects who really
have the indication. One of the most controversial issues
of cognitive intervention is its various effect on patients
with different level of cognitive ability. Some large-scale
studies, such as ACTIVE study, did not precisely differ-
entiate their participants. Positive effect was not proved
to retain in participants with or without risk of AD.
Though less side effect, cognitive intervention still has
costs and is time-consuming. The duration of interven-
tions varies among all studies. In some studies for nor-
mal older adults, participants attended the training for
as long as 2 years, with a total of 270 h. In more studies,
the training period ranged from 3 h to more than 100 h.
Every session varied from 30 to 90 min in different stud-
ies. What is the relationship between training effect and
the duration of intervention? Unfortunately, no one
observed the quantitative interaction between duration
and extent of improvement. Regarding these uncertainty,
it is necessary to figure out who do need and could
benefit from such interventions. A retrospective study
suggested that neuropsychological profile helped differ-
entiate subjects who respond better [87]. More neuro-
biological markers might make the intervention a more
precise therapy.
Another problem is the duration of effect since inter-
vention ends. The benefits of name-face association
training were observed after 1 week [88], or after 1
month [89], and the participants could recognize the
training material faster and with fewer errors [58].
Moreover, benefits of speed processing training were
observed after 2 years with booster sessions over the
course of 11 months [90]. Memory strategy worked as
an enhancer of effect sustainment [55, 91], and it was
not maintained after three [62] and four [91] months.
Goal-oriented cognitive rehabilitation brought increase
in self-performance and quality of life, which remained
for 6 months [61]. However, the potential mechanisms
of the prolonged effect are still unclear. The clarification
of neurobiological changes stimulated by cognitive inter-
vention might help a better design of cognitive program.
Finally, though functional MRI provided some evi-
dence for brain activity changes, it has own methodo-
logical limitations. Blood oxygenation level dependent
contrast (BOLD) in resting or task-related fMRI were
mainly used to reflect brain activity. Various statistical
methods were adopt to analyze BOLD data. Regional
homogeneity, amplitude of low-frequency fluctuation
(ALFF), fractional ALFF (fALFF) were once used as rep-
resentation of regional activities in AD [92, 93], while
some used Independent Component Analysis and
Granger Causality Analysis to evaluate connectivity [94,
95]. Recently, fMRI validity was seriously questioned for
its high false-positive rate from generally used software
packages (SPM, FSL, AFNI) [96].
Cognitive stimulation for animals
Studies above have shown that the progression of de-
mentia could be slowed down in the patients who have
cognitively stimulating activities. These discoveries point
to the conclusion that cognitive interventions intellec-
tually may not only improve memory performance but
also prevent future cognitive decline. Some difficulties
met in clinical trials above asked for further exploration
in neurobiological way.
Early experimental studies of brain stimulation on
laboratory rodents
We now manipulate mental exercise as stimulating brain
which acts a positive role on AD and other forms of
dementias via neuroprotective and compensatory mech-
anism. Existing animal models that are most relevant to
our understanding of non-pharmacological therapy in-
clude those which utilize environmental or cognitive
stimulation as experimental paradigms to alter levels of
cognitive activity. In order to attempt to investigate the
mechanistic underpinnings of mental exercise in cogni-
tive function, we should first understand early experi-
mental studies of brain stimulation- environmental
enrichment (EE) on animal models. EE has defined
broadly as the use of housing conditions that offer en-
hanced sensory, motor, and cognitive stimulation of
brain in comparison with standard caging [97]. In the
late 1940s, Donald O. Hebb [98] was the first to propose
the “enriched environment” as an experimental concept
and reported anecdotally that the laboratory rats that he
took home as pets solved test problems more easily than
the rats kept at the laboratory. While his research did
not investigate the brain nor use standardized and
enriched environments. More quantitative and con-
trolled EE studies needed to be conducted to test this
paradigm systematically. In 1960, Mark Rosenzweig
found the rats growing up in the cages with toys, ladders
and tunnels showed higher enzyme cholinesterase activ-
ity [99]. The following work reported that living in
enriched environment altered the function and structure
of the brain, and increased cerebral cortex volume [100],
thickness [101] and wet weight [102], greater synapse
and glial numbers [103]. At that time brain weight and
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structure were considered a stable characteristic not
subject to environmental influences.
From these early conclusions regarding the effects of
EE, increasingly refined studies have progressed to show-
ing effects at the cell and molecular levels. Adult rats
were placed into enriched housing conditions for 1 year
and showed significantly higher levels of nerve growth
factor [104]. Another study reported the increased NGF,
BDNF and NT-3 protein levels of EE adult rats com-
pared with age-matched isolated condition ones [105].
Researchers also found EE affected the expression levels
of a number of genes (microfibrilar protein, micro-
tubule- associated protein 4, PSD-95/SAP90A, Bcl2/Bax,
synaptobrevin, for example) involved in neuronal struc-
ture, synaptic signaling, and plasticity [106]. As research
deepened, investigators have found that EE facilitated
repair to the brain in a variety of situations, including se-
vere traumatic brain injury [107, 108], developmental
lead exposure [109], and stroke [110] prenatal stress
[111], dark rearing [112], and even aging [113].
Numerous cognitive studies about how EE affected the
brain had been also proposed. In the intact animals, EE
could dramatically improve cognitive abilities [113–115].
In the brain-lesioned animals, EE was beneficial in at-
tenuating cognitive deficits caused by cerebral contusion
[107, 110, 116, 117]. Since then, a large volume of litera-
ture has evolved describing the effects of EE in a number
of different transgenic mouse models of AD (Table 2).
Environmental enrichment-cognitive stimulation on
animal models of AD
Many studies had shown that placing animals in com-
plex environments for extended period improved their
cognitive performance and brain activity in normal mice
and rats. Whether did EE show beneficial effects on be-
havior and cognition in an animal model of AD? There
were several mouse models of neurodegeneration like
AD studying the modulating effects of environmental
factors: transgenic mice overexpressing amyloid precur-
sor protein (APP) and/or presenilin (PS)-1, AD11 mice
expressing anti-nerve growth factor (NGF) antibodies
and double transgenic TgCRND8 mice overexpressing
the Swedish and Indiana mutations in the human APP.
In these researches, the mouse models were given exten-
sive enrichment such as cognitive stimulation or com-
plex housing condition. Cognitive impairment and
neuronal alterations elicited by neurodegenerative path-
ologies were evaluated to determine if they had been
ameliorated or rescued by EE. If a long-lasting exposure
to EE, the mouse model should display a delayed onset
or progression of cognitive impairment.
Before the onset of amyloid formation, APP/PS1 trans-
genic mice exposed to the long term of EE from 2 to
8 months of age would show mitigated learning and
memory deficits. For example, long term EE led to im-
provement in cognitive function but without decreasing
brain beta-amyloid deposition in the aged APPsw mice
[118]. Jankowsky, J. L reported that 2-month-old APP/
PS1 mice were placed into enriched environment for
6 months, and they swam shorter distances to reach the
hidden platform in water maze and more efficiently re-
membered the platform position. The performance of
learning and memory were both normalized to the level
of standard-housed non-transgenic mice [119]. Lazarov
et al. found pronounced reduction in the levels of cere-
bral beta-amyloid peptides and amyloid deposits in the
same EE APP/PS1 mice [120].
AD11 mice developed age-dependent neurodegenera-
tion including hallmarks of human AD and exhibited
progressive memory impairment [121, 122]. Exposed to
EE before the onset of behavior deficits for a long time
in AD11 mice resulted in preserved visual recognition
memory and spatial memory in comparison to non-EE
AD11 mice. EE AD11 mice displayed a stronger curios-
ity when faced a novel object than a familiar object and
showed the same ability with wild-type mice on a water
maze task [123].
In the TgCRND8 mice, EE had increased exploratory
behavior and decreased anxiety-related behavior but
could not clearly ameliorate deficits in learning and
memory performance [124]. More recent evidence also
suggested EE may reduce the cerebral oxidative stress
[125], compensate for the effects of stress on disease
progression [126], prevent astroglial pathological
changes [127] and lessen the cognitive decline [128]. In
the Tau-Tg transgenic mice, the NFTs decreased in EE
mice [129]. In senescence-accelerated prone mice (SAM-
P8),EE gave rise to significant beneficial effects at the
molecular, cellular, and behavioral levels during brain de-
velopment, particularly in the hippocampus [130]. In this
part, EE provided animals with more novel and complex
environment, and thus stimulated cognitive processes,
particularly learning and memory. This evidence in AD
mice indicated that enhanced cognitive stimulation of
EE played a pivotal role in the protection from cognitive
impairment.




Adult neurogenesis is shown to continue in two parts of
brains: the subventricular zone (SVZ) lining the lateral
ventricles and subgranular zone (SGZ). In fully adult
mammals, new neurons born in SVZ migrate anteriorly
into the olfactory bulb (OB), where they mature into
local interneurons [131–133]. Adult-generated olfactory
interneurons contribute to odor discrimination and
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olfactory memory [134–136]. It has long been convinced
that the hippocampus plays critical role in learning and
memory [137], so the production of neurons in the adult
hippocampal dentate gyrus (DG) has introduced the
possibility of a new form of plasticity that could sustain
memory processes. A growing body of evidence support
that hippocampal neurogenesis improves pattern separ-
ation and spatial memory [138, 139].
Hippocampal neurogenesis could be influenced by sev-
eral environmental factors and stimuli [140, 141]. While
aging was the greatest environmental risk factor, increas-
ing evidence showed noteworthy alteration in neurogen-
esis took place much earlier than the onset of hallmark
lesions or neuronal loss in AD [142, 143]. In aged and
AD brains, the proliferation of progenitor cells and their
numbers were significantly declined (for review see
[144]). The levels of stem cell factor (SCF) which sup-
ported neurogenesis in the brain were reduced in the
plasma and cerebrospinal fluid of AD patients [145]. In
WT mice, EE could enhance hippocampal cell prolifera-
tion [146, 147]. And transient receptor potential-canonical
1(TRPC1) was indispensable for the EE-induced hippo-
campal neurogenesis [148].
Previous studies in transgenic models of AD had gen-
erated mounting evidence supporting alterations in
neurogenesis. Short-term exposure to EE led to a strik-
ing increase in new neurons and a substantial improve-
ment in behavior performance [149]. Studies in several
transgenic mice expressing AD-linked gene suggested
that adult neurogenesis could be altered by external
neurogenic stimulus- enriched environment. EE was re-
ported to increase hippocampal DG neurogenesis and
improve their water maze performance in APP23 mice
[150, 151]. Enriched housing environment could also im-
prove cognitive performance in PS1/PDAPP transgenic
mouse models [152]. In PS1 and PS2 conditional double
knockout mice, EE had been shown to be able to induce
neurogenesis and effectively enhance memory of the
brain [153]. In APP/PS1 double transgenic mice, EE for
7 weeks efficiently ameliorated early hippocampal-
dependent spatial learning and memory deficits [154].
Complex environment had been reported to rescue im-
paired neurogenesis, reduce Aβ levels and amyloid de-
position, and significantly enhance hippocampal LTP in
APP/PS1 mice [120, 155]. EE applied to SAMP8 at
young ages resulted in an increase in NeuN and Ki67
expression [130]. Thus, the proliferation of new
neurons which had a reciprocal connection with AD
pathogenesis would provide new opportunities for cell
therapy for AD.
Although there are lots of studies reporting that EE
could increase neurogenesis in DG of the adult hippo-
campus, neurogenesis in other parts of the brain- the
subventricular zone(SVZ) or olfactory bulb (OB) system
may be affected by other forms of enhanced stimulation
significantly [156]. Olfactory enrichment- a specific form
of enhanced sensory stimulation, does appear to increase
neurogenesis in the OB [157] and additionally the
piriform cortex [158].
Neuronal and glial developments
Neurons, neuroglia (including astrocytes, oligodendro-
cytes and microglia) and ependymal cells make up the
complex structure of the adult central nervous system
(CNS). Adult neurogenesis bridges between neuronal
and glial neurobiology in an intriguing way. When the
enrichment environment altered the neurogenesis, the
differentiation and development of neuron and glial were
always changed at the same time. Increased neuronal
differentiation in DG was observed in the EE treated rats
and the density of NeuN positive cells was enhanced
without new neurons [159]. As many as 90% of cells in
the brain are thought to be glial, therefore it is not diffi-
cult to understand that the beneficial effects of EE in-
volve glial cell types. There is in fact evidence that EE
could alter the numbers of glial in specific brain regions.
EE could lead to a significant increase in the number of
new astrocytes in layer 1 of the motor cortex [160]. In
CA1 region, environmental condition increased the
number of astrocytes [161] and stimulated astrocytes to
acquire a more stellate morphology [162]. Two months
old rats enriched for 7 weeks showed increased antigen
expression of both astrocytes and microglia within DG
[163]. Glia cells are known to interact extensively with
neuron in the brain. Astrocytes secrete factors that
promote neuron survival and provide crucial support
to neurons. Oligodendrocytes are essential regulators
of neurotransmission along myelinated axons. These
reports of neuronal effects or non-neuronal effects of
EE were interesting in light of evidence that EE plays
an important role in modulating neurogenesis and
cognition in AD.
Molecular mechanisms improving cognitive activity
We have now outlined various important structural and
cellular changes that have been observed to occur in the
animal brain exposure to EE. Evidence in support of
such behavioral and cellular effects on molecular mecha-
nisms has been gathered using a range of approaches.
Examples of such molecular classes including specific
neurotrophins, neurotransmitters and neuromodulator
receptors, and synaptic signaling pathways have been
validated via gene/protein studies.
Activity dependent modulation of gene expression
One early study demonstrated the attenuated expression
of AP-2 in the CA2 and CA3 subfield of hippocampus
after exposure to EE for 30 days [164]. In adult rats, EE
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has been shown to upregulate 3H-AMPA binding in the
hippocampus by decreasing the capacity of calcium or
phosphatidylserine without changes in mRNAs for
AMPA receptors [165]. Male rats exposed to EE for
30 days could result in significant higher expression of
5-HT1A receptor mRNA in the hippocampus [166], de-
creased level of EAAC1 mRNA and increased level of
NMDA mRNA specifically in the hippocampus [167].
EE could also increase the mRNA expression levels of
5α-reductase-1 and 3α-hydroxysteroid dehydrogenase,
which catalyze synthesis of allopregnanolone from
progesterone [168].
A more detailed research analyzed gene expression
changes in the cortex of mice and found a large number
of genes changed in response to enrichment [106].
Another study analyzed the effects of enriched sur-
roundings with DNA microarrays and found the hippo-
campus was more responsive to environment stimuli
than sensorimotor cortex [169]. Others have also shown
the expression of immediate-early gene (IEG) Zif268
could be induced to higher level in the CA3/CA4 region
which was associated with enhanced spatial learning task
[170]. In NMDAR1-Knockout mice which showed mem-
ory impairment, the expression levels of 104 genes in-
volved in multiple signal pathways could be recovered or
reversed by EE [171]. Similarly, levels of CREB were in-
creased following EE [172]. With the growing knowledge
regarding environment and gene interactions, the frame-
work has been built by an association between gene-
environment interactions and disease [173].
Furthermore, there are still numbers of evidence that
non-coding RNA species such as microRNAs (MiR)
could also be modulated by EE. For example, MiR-183
expression could be upregulated by EE and reduce
anxiety-like behavior in mice [174]. MiR-124a showed a
similar performance following enriched environment
condition [175]. MiR-325 was downregulated in 3 × Tg
AD mice but upregulated by EE, which may open new
avenues for the studies of treating AD [176]. Until now,
this field of exploration is now relatively new, therefore
many questions regarding the epigenetic impacts of EE
remain unsolved. While the genomic and biochemical
tools available are evolving rapidly, there will no doubt
be great progress in the near future.
Oxidative stress
Previous studies have demonstrated that oxidative stress
is an important factor contributing to the onset and pro-
gression of AD and the brain is sensitive to oxidative im-
balance. Oxidative stress results from increased
production of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) [177] and possibly precedes Aβ
and tau aggregation. The exact mechanisms by how EE
provides protection against oxidative damage in the
brain with AD remain speculative. In aged rats, complex
EE modifies exploration activity, cognition and biochem-
ical markers which may be mediated by oxidative stress
levels [178]. Long term exposure to EE from adult age
would increase life span in mice [179]. EE rats showed
higher values for antioxidant measures and lower values
for oxidative stress parameters than control animals
[180]. In transgenic mice with Alzheimer-like pathology,
cognitive stimulation in the form of EE attenuated
pro-oxidative processes and triggered anti-oxidative
defense mechanisms by diminishing reactive oxygen
and nitrogen species, downregulating pro-inflammatory
and pro-oxidative mediators, decreasing expression of
pro-apoptotic caspases, and increasing the activities of
SOD1 and SOD2 [125]. In another study, EE increased
anti-oxidative SOD1 protein and decreased the levels of
nitro-tyrosine- a prominent biomarker for oxidative dam-
age [181] .
Neurotrophin, neurotransmitter and neuromodulator
signaling pathway
Modulation of neurotrophin expression and changes in
neurotransmitters and neuromodulators are related to
EE according to extensive findings. The primary effect of
increased cognitive activity must be via enhanced synap-
tic and neuronal activity in the relevant neural circuitry.
So, it is not difficult to image that molecular effects
induced by EE have been shown to involve changes in
neurotransmitters. Numbers of studies have shown that
EE in animals increased the expression levels of brain-
derived neurotrophic factor (BDNF), nerve growth
factor (NGF) and vascular endothelial growth factor
(VEGF) [182].
In rats with cognitive impairment, the levels of BDNF
decreased in the hippocampus and EE exposure could
up-regulate the decreased protein levels of BDNF [183].
More studies explained that the enhancement of learn-
ing and memory observed after treatment of EE is caus-
ally dependent on increased neurogenesis in DG. And
BDNF was required for neurogenesis in the adult hippo-
campus [184] and might be responsible for learning and
memory enhancement [185]. EE could significantly
increase hippocampal BDNF levels accompanied by
increased astrocytes (GFAP+) and microglia (Iba1+)
antigen expression [163]. As BDNF supports hippocam-
pal long-term potentiation (LTP), EE also improved
synaptic plasticity and cognition through increased levels
of BDNF [186].
The experience of APP/PS1 mice in EE would upregu-
late critical signaling that plays a major role in learning
and memory, such as BDNF, IGF-1, N-methyl-D-aspartic
acid receptor (NMDAR) and CREB transcripts [187].
NGF is another intensively investigated neurotrophin,
when exposed to EE, the levels of NGF was increased
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either [188, 189] in the cerebral cortex, hippocampal for-
mation, basal forebrain, and hindbrain in EE mice [105].
The levels of NGF mRNA were significant higher in rats
housed in a stimulus-rich environment than those in
single cages [190]. Short-term EE also increased NGF
concentration and improved memory, early neuronal
survival in DG [191]. Researchers draw attention to
BDNF and NGF mostly because they appeared to be
most labile in their expression dynamics and they are
important in brain development, function and disease.
Conclusion and perspectives for the future
As one of non-pharmacological therapies, cognitive ac-
tivity could benefit cognitive function, and thus life qual-
ity of patients and their families. These reviewed clinical
studies above highlighted the positive effects of cognitive
activity on cognitive ability, well-beings, behavior, and
mood in older adults or patients with cognitive decline.
We also reviewed the molecular and cellular mecha-
nisms underlying this non-pharmacological therapy.
Based on these clinical trials and meta analysis, we
recommend some key features of training that often as-
sociated with positive outcomes. Firstly, multi-domain
tasks contribute more to cognition [19, 192]. As trained
effect could hardly transfer to untrained domains, multi-
domain trainings are generally adopted and recom-
mended. Evidence from neuroimaging and animal
research suggested that transfer effect could be maxi-
mized when tasks are designed to stimulate common
brain regions (e.g., hippocampus, striatum) [193, 194].
Besides, challenging tasks for individuals are much more
helpful in promoting cognitive ability: training is not
learning until the participant can complete the task per-
fectly. During this period, challenging tasks are helpful
for the survival of new neurons [193]. Computerized
cognitive training is a lucrative and expanding business.
It could easily offer standard and self-adaptive tasks with
various levels of difficulty. At the end of training, per-
formance could be evaluated and participants know how
well they did. It brings more convenience, as well as less
supervision. The researchers identified small but signifi-
cant effect, while “do-it-yourself” training at home did
not produce cognitive improvements [19]. Motivational
strategies also can be applied to increase treatment
adherence. As described above, training package is rec-
ommended, which composes cognitive training package,
behavioral therapy for hopelessness and low expectations
of success, and a motivational milieu [195]. Compared
with control group, AD patients receiving the training
package reported fewer depressive symptoms. Fewer de-
pression also leads to better memory improvement and
better quality of life [196, 197]. Errorless learning has its
special advantage in mild to moderate AD patients. It
provides more clues and leads to the only correct
answer, which lessens confusion from the difference
between correct answer and incorrect response. More
importantly, this training process encourages elders to
learn by clues in daily life [89, 198].
However, the heterogeneity of cognitive intervention
poses great difficulty for a safe conclusion. Combining
data from trials of different sample size can result in
overestimating the precision of smaller studies. Because
of limitation in clinical trials mentioned in Section Why
we turn to bench for more help?, we turn to animal
studies for more help.
Evidence from epidemiology and animal model studies
suggests that the onset of neurodegenerative diseases
could be modulated by environmental factors [199].
However, understanding the mechanism of EE requires
animal models showing both behavioral and intrinsic
changes which could link data from molecular through
to systems levels. The studies compared the behavioral,
cellular and molecular data on animal models under EE
versus standard conditions. The positive effects of EE in-
clude increased adult neurogenesis, elevated or declined
gene expression, reduced oxidative stress and subse-
quently reduced anxiety-like behaviors and improved
cognitive performance. This enhanced understanding of
EE may provide insight into the mechanistic basis and
lead to novel therapeutic approaches which boost en-
dogenous cognitive activity, and thus delay onset of a
range of devastating AD and other dementias (Fig. 1).
We find EE has positive influence on normal aging
and transgenic AD mouse, which could induce brain
structure to produce a variety of changes. The change
on anatomy includes the increases of brain weight,
thickening of cerebral cortex and enlargement of hippo-
campus volume, etc. On cellular levels, EE could in-
crease the proliferation of neural progenitor cells,
production of newly generated neurons, the dendritic
branches and tree density and the number of neuronal
synapsis. These changes are most obvious in hippocam-
pus and cerebral cortex. EE also could change the
morphology of glia cells (including astrocyte and oligo-
dendroglia cell) and promote the glial cell proliferation
in the brain and cerebellum. EE could also induce vari-
ous neural active substance changes, BDNF, VEGF, NGF
and so on. These growth factors play important role on
neurogenesis and neural network, which helps neuron
development, differentiation and survival. In these ways,
EE could improve the learning ability and cognition.
Several questions remain unclear. Classic water maze
was usually applied in mice around 8 months old. How-
ever, most EE studies used transgenic AD mice of rela-
tive young age, about 2–3 month-old. Thus, the effect of
EE in elder mice was still unclarified. Maybe older mice
should be used on EE in the following days. Besides, few
study concerns how EE influence neuronal death and
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related mechanism for its non-ignorable role in neural
circuit. A more difficult challenge is linking animal
model data with clinical studies. Finally, the questions
we raised in Section Why we turn to bench for more
help? were only partly answered in animal studies. We
could conclude that the pathological changes in AD
model could be modified by cognitive interventions. The
best duration and long-term effect of these intervention
still remain unclear. An overall systematic explanation
for the internal mechanism of EE should be given in
further studies.
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Fig. 1 The two circles illustrate the beneficial effect of cognitive training in both clinical and laboratorial studies. The “bedside” semi-circle includes
major cognitive trainings that have been tried in healthy old adults, MCI and AD patients. In contrary to heterogeneity of human, mouse models
in “bench” semi-circle are nearly monotonous: enriched environment, which offers colorful housing condition including social, sensory and
cognitive enrichment. Social enrichment allows more mice dwelling at a large cage to gain companionship and communication. Sensory enrichment
provides animals with more novel and complex environments, ladders, colorful toys and various objects for example. And cognitive enrichment
stimulates animals’ cognitive processes, particularly learning and memory, in form of maze solving. Exposure to EE could improve animals’ cognitive
performance and rescue brain atrophy, which elicited by a number of key molecular and cellular factors, acting at a single neuron or neural circuit
level. The shared part of two circles demonstrates neurological effect of interventions for both human and mice, including behavioral, brain structural,
neuronal and neural chemicals changes
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